Abstract
The development of hormone antagonists, or compounds which can reverse the physiological effects of hormone hypersecretion, has been a desirable and achievable goal for many small molecular weight hormones. The spectacular successes achieved with hormone antagonists such as spironolactone, RU-486 and cimetidine have stimulated pharmacologists and pharmaceutical companies to use similar strategies in the search for an antagonist to thyroid hormone. For the most part the development of steroid hormone antagonists followed a classical chemical synthetic route; systematic modifications either to the ring structure or to side chains of the steroid were carried out, the new compounds were tested in a hormone bioassay ultimately leading to clinical trials, and subsequently effective compounds were applied in clinical practice. Consequently, there is now a range of compounds which are safely able to inhibit the actions of mineralocorticoids, glucocorticoids, androgens and progestagens and which have extensive clinical utility. These compounds are also remarkably useful tools which can be used to understand the molecular mechanisms of steroid hormone action in the laboratory.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Angel RC, Botta JA, Morero RD, Farias RN (1990) Solubilization and purification of a membrane-associated 3,3’,5-tri-iodo-L-thyronine-binding protein from rat erythrocytes. Biochem J 270: 577–582
Ashizawa K, Willingham MC, Liang C-M, Cheng S-Y (1991) In vivo regulation of monomer-tetramer conversion of pyruvate kinase subtype M2 by glucose is mediated via fructose 1,6-biphosphate. J Biol Chem 266: 16842–16846
Ashizawa K, Cheng S-Y (1992) Regulation of thyroid hormone receptor-mediated transcription by a cytosol protein. Proc Natl Acad Sci USA 89: 9277–9281
Bakker O, van Beeren HC, Wiersinga WM (1994) Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone β 1-receptor protein. Endocrinology 134: 1665–1670
Baniahmad A, Ha I, Reinberg D, Tsai S, Tsai M-J, O’Malley BW (1993) Interaction of human thyroid hormone receptor β with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc Natl Acad Sci USA 90: 8832–8836
Baniahmad A, Leng X, Burris TP, Tsai SY, Tsai M-J, O’Malley BW (1995) The τ 4 activation domain of the thyroid hormone receptor is required for release of a putative co-repressor(s) necessary for transcriptional silencing. Mol Cell Biol 15: 76–86
Barlow JW, Raggatt LE, Lim C-F, Munro SL, Topliss DJ, Stockigt JR (1989) The thyroid hormone analogue SKF L-94901: nuclear occupancy and serum binding studies. Clin Sci 76: 495–501
Barlow JW, Raggatt LE, Lim C-F, Kolliniatis E, Topliss DJ, Stockigt JR (1991) The thyroid hormone analogue SKF-94901 and iodothyronine binding sites in mammalian tissues: Differences in cytoplasmic binding between liver and heart. Acta Endocrinol (Copenh) 124: 37–44
Barlow JW, Curtis AJ, Raggatt LE, Loidl NM, Topliss DJ, Stockigt JR (1994) Drug competition for intracellular triiodothyronine-binding sites. Eur J Endocrinol 130: 417–421
Barlow JW, Raggatt LE, Scholz GH, Loidl NM, Blok RB, Topliss DJ, Stockigt JR (1996) Preferential inhibition of cytoplasmic T3 binding is associated with reduced nuclear binding in cultured cells. Thyroid 6: 47–51
Beato M (1989) Gene regulation by steroid hormones. Cell 56: 335–344
Blondeau J-P, Osty J, Francon J (1988) Characterization of the thyroid hormone transport system of isolated hepatocytes. J Biol Chem 263: 2685–2692
Blondeau J-P, Beslin A, Chantoux F, Francon J (1993) Triiodothyronine is a high-affinity inhibitor of amino acid transport system L, in cultured astrocytes. J Neurochem 60: 1407–1413
Bradley D, Towle H, Young W (1992) Spatial and temporal expression of α- and β- thyroid hormone receptor mRNAs, including the β 2-subtype, in the developing mammalian nervous system. J Neurosci 12: 2288–22302
Brtko J, Knopp J, Baker ME (1993) Inhibition of 3,5,3’-triiodothyronine binding to its receptor in rat liver by protease inhibitors and substrates. Mol Cell Endocrinol 93: 81–86
Casanova J, Horowitz ZD, Copp RP, McIntyre WR, Pascaul A, Samuels HH (1984) Photoaffinity labeling of thyroid hormone nuclear receptors. J Biol Chem 259: 12084–12091
Cattini PA, Kardami E, Eberhardt NL (1988) Effect of butyrate on thyroid hormone-mediated gene expression in rat pituitary tumour cells. Mol Cell Endocrinol 56: 263–270
Centanni M, Robbins J (1987) Role of sodium in thyroid hormone uptake by rat skeletal muscle. J Clin Invest 80: 1068–1072
Centanni M, Sapone A, Taglienti A, Andreoli M (1991) Effect of extracellular sodium on thyroid hormone uptake by mouse thymocytes. Endocrinology 129: 2175–2179
Chalmers DK, Scholz GH, Topliss DJ, Kolliniatis E, Munro SL, Craik DJ, Iskander MN, Stockigt JR (1993) Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity. J Med Chem 36: 1272–1277
Chatterjee VK, Tata JR (1992) Thyroid hormone receptors and their role in development. Cancer Sury 14: 147–167
Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454–457
Cheng S-Y, Hasumura S, Willingham MC, Pastan I (1986) Purification and characterization of a membrane-associated 3,3’,5-triiodo-L-thyronine binding protein from a human carcinoma cell line. Proc Natl Acad Sci USA 83: 947–951
Cheng S-Y, Ransom SC, McPhie P, Bhat MK, Mixson AJ, Weintraub BD (1994) Analysis of the binding of 3,3’,5-triiodo-L-thyronine and its analogues to mutant human β 1 thyroid hormone receptors: a model of the hormone binding site. Biochemistry 33: 4319–4326
Childs GV, Taub K, Jones KE, Chin WW (1991) Triiodothyronone receptor β-2 messenger RNA expression by somatotrophs and thyrotropes: effect of propylthiouracil-induced hypothyroidism in rats. Endocrinology 129: 2767–2773
Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, Braverman LE, Pinchera A (1994) Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 134: 2277–2282
Crowe TC, Cowen NL, Loidl NM, Topliss DJ, Stockigt JR, Barlow JW (1995) Down-regulation of thyroxine-binding globulin messenger ribonucleic acid by 3,5,3’triiodothyronine in human hepatoblastoma cells. J Clin Endocrinol Metab 80: 2233–2237
Crowe TC, Loidl NM, Payne KL, Topliss DJ, Stockigt JR, Barlow JW (1996) Differential modulation of thyroid hormone responsiveness by retinoids in a human cell line. Endocrinology 137: 3187–3192
Dalman FC, Koenig RJ, Perdew GH, Massa E, Pratt WB (1990) In contrast to the glucocorticoid receptor, the thyroid hormone receptor is translated in the DNA binding state and is not associated with hsp90. J Biol Chem 265: 3615–3618
Damm K, Thompson CC, Evans RM (1989) Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist. Nature 339: 593–597
Davis KD, Lazar MA (1992) Selective antagonism of thyroid hormone action by retinoic acid. J Biol Chem 267: 3185–3189
Docter R, Krenning EP, de Jong M, Hennemann G (1993) The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism. Clin Endocrinol (Oxf) 39: 499–518
Dozin B, Cahnmann HJ, Nikodem VM (1985) Comparative characterization of thyroid hormone receptors and binding proteins in rat liver nucleus, plasma membrane, and cytosol by photoaffinity labeling with L-thyroxine. Biochemistry 24: 5203–5208
Drvota V, Bronnegard M, Hagglad J, Barkhem T, Sylven C (1995) Downregulation of thyroid hormone receptor subtype mRNA levels by amiodarone during catecholamine stress in vitro. Biochem Biophys Res Comm 211: 991–996
Elfahime EL, Felix JM, Koch B (1994) Antagonistic effects of retinoic acid and triiodothyronine in the expression of corticoid-binding globulin (CBG) by cultured fetal hepatocytes. J Steroid Biochem Molec Biol 48: 467–474
Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889–895
Everts ME, Docter R, van Buuren JCJ, van Koetsveld PM, Hofland LJ, de Jong M, Krenning EP, Hennemann G (1993) Evidence for carrier-mediated uptake of triiodothyronine in cultured anterior pituitary cells of euthyroid rats. Endocrinology 132: 1278–1285
Everts ME, Visser TJ, Moerings EPCM, Tempelaars AMP, van Toor H, Docter R, de Jong M, Krenning EP, Hennemann G (1995) Uptake of 3,3’,5,5’tetraiodothyroacetic acid and 3,3’,5’-triiodothyronine in cultured rat anterior pituitary cells and their effects on thyrotropin secretion. Endocrinology 136: 4454–4461
Fanjul AN, Farias RN (1991) Novel cold-sensitive cytosolic 3,5,3’-triiodo-L-thyroninebinding proteins in human red blood cell. J Biol Chem 266: 16415–16419
Fanjul AN, Farias RN (1993) Cold-sensitive cytosolic 3,5,3’-triiodo-L-thyroninebinding protein and pyruvate kinase from human erythrocytes share similar regulatory properties of hormone binding by glycolytic intermediates. J Biol Chem 268: 175–179
Freedman LP, Luisi BF (1993) On the mechanism of DNA binding by nuclear hormone receptors: a structural and functional perspective. J Cell Biochem 51: 140–150
Gerrelli D, Huntriss JD, Latchman DS (1994) Antagonistic effects of retinoic acid and thyroid hormone on the expression of the tissue-specific splicing protein SmN in a clonal cell line derived from rat heart. J Mol Cell Cardiol 26: 713–719
Giguere V, Ong ES, Segui P, Evans RM (1987) Identification of a receptor for the morphogen retinoic acid. Nature 330: 624–629
Glass C (1994) Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15: 391–407
Goldstein RA, Katzenellenbogen JA, Luthey-Schultzen ZA, Seielstad DA, Wolynes PG (1993) Three-dimensional model for the hormone binding domain of steroid receptors. Proc Natl Acad Sci USA 90: 9949–9953
Gotzsche LB (1993) Beta-adrenergic receptors, voltage-operated Ca2+-channels, nuclear triiodothyronine receptors and triiodothyronine concentration in pig myocardium after long-term low-dose amiodarone treatment. Acta Endocrinologica (Copenh) 129: 337–347
Gotzsche LB, Orskov H (1994) Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo-and hyperthyroid rats. Eur J Endocrinol 130: 281–290
Gonçalves E, Lakshmanan M, Cahnmann HJ, Robbins J (1990) High-affinity binding of thyroid hormones to neuroblastoma plasma membranes. Biochim Biophys Acta 1055: 151–156
Harding PP, Duester G (1992) Retinoic acid activation and thyroid hormone repression of the human alcohol dehydrogenase gene ADH3. J Biol Chem 20: 14145–14150
Hashizume K, Miyamoto T, Ichikawa K, Yamauchi K, Kobayashi M, Sakurai A, Ohtsuka H, Nishii Y, Yamada T (1989a) Purification and characterization of NADPH-dependent cytosolic 3,5,3’-triiodo-L-thyronine binding protein in rat kidney. J Biol Chem 264: 4857–4863
Hashizume K, Miyamoto T, Ichikawa K, Yamauchi K, Sakurai A, Ohtsuka H, Kobayashi M, Nishii Y, Yamada T (1989b) Evidence for the presence of two active forms of cytosolic 3,5,3’-triiodo-L-thyronine (T3)-binding protein (CTBP) in rat kidney. J Biol Chem 264: 4864–4871
Hashizume K, Miyamoto T, Yamauchi K, Ichikawa K, Kobayashi M, Ohtsuka H, Sakurai A, Suzuki S, Yamada T (1989c) Counterregulation of nuclear 3,5,3’triiodo-L-thyronine (T3) binding by oxidised and reduced-nicotinamide adenine dinucleotide phosphates in the presence of cytosolic T3-binding protein in vitro. Endocrinology 124: 1678–1683
Higueret P, Pallet V, Coustaut M, Audouin I, Begueret J, Garcin H (1992) Retinoic acid decreases retinoic acid and triiodothyronine nuclear receptor expression in the liver of hyperthyroidic rats. FEBS Lett 310: 101–105
Hillier AP (1970) The binding of thyroid hormones to phospholipid membranes. J Physiol 211: 585–597
Hodin RA, Lazar MA, Wintman BI, Darling DS, Koenig RJ, Larsen PR, Moore DD, Chin WW (1989) Identification of a thyroid hormone receptor that is pituitary-specific. Science 244: 76–79
Hodin RA, Lazar MA, Chin WW (1990) Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone. J Clin Invest 85: 101–105
Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK, Rosenfeld MG (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397–404
Hsu J-H, Zavacki AM, Harney JW, Brent GA (1995) Retinoid-X receptor ( RXR) differentially augments thyroid hormone response in cell lines as a function of the response element and endogenous RXR content. Endocrinology 136: 421–430
Ichikawa K, Hashizume K, Kobayashi M, Nishii Y, Ohtsuka H, Suzuki S, Takeda T, Yamada T (1992) Heat shock decreases nuclear transport of 3,5,3’-triiodo-Lthyronine in clone 9 cells. Endocrinology 130: 2317–2324
Ishigaki S, Abramovitz M, Listowsky I (1989) Glutathione-S-transferases are major cytosolic thyroid hormone binding proteins. Arch Biiochem Biophys 273: 265–272
Jennings AS, Ferguson DC, Utiger RD (1979) Regulation of the conversion of thyrox- ine to triiodothyronine in the perfused rat liver. J Clin Invest 64: 1614–1623
de Jong M, Docter R, van der Hoek HJ, Vos RA, Krenning EP, Hennemann G (1992) Transport of 3,5,3’-triiodothyronine into the perfused rat liver and subsequent metabolism are inhibited by fasting. Endocrinology 131: 463–470
Kato H, Fukuda T, Parkison C, McPhie P, Cheng S-Y (1989) Cytosolic thyroid hormone-binding protein is a monomer of pyruvate kinase. Proc Natl Acad Sci USA 86: 7861–7865
Katz D, Lazar MA (1993) Dominant negative activity of an endogenous thyroid hormone receptor variant (α 2) is due to competition for binding sites on target genes. J Biol Chem 268: 20904–20910
Katz D, Reginato MJ, Lazar MA (1995) Functional regulation of thyroid hormone receptor variant TRa2 by phosphorylation. Mol Cell Biol 15: 2341–2348
van der Klis FRM, Nijenhuis AA, Wiersinga WM (1991) Inhibition of nuclear T3 binding by fatty acids liberated from nuclear membranes via phospholipase C. Int J Biochem 23: 1031–1034
Kragie L, Doyle D (1992) Benzodiazepines inhibit temperature-dependent L-[125I] triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines. Endocrinology 130: 1211–1216
Krenning EP, Docter R, Bernard HF, Visser RJ, Hennemann G (1981) Characteristics of active transport of thyroid hormone into rat hepatocytes. Biochem Biophys Acta 676: 314–320
Krenning EP, Docter R (1986) Plasma membrane transport of thyroid hormone. In: Henneman G (ed) Thyroid hormone metabolism. Dekker, New York, pp 107–131
Lakshmanan M, Gonçalves E, Lessly G, Foti D, Robbins J (1990) The transport of thyroxine into mouse neuroblastoma cells, NB41A3: the effect of L-system amino acids. Endocrinology 126: 3245–3250
Lane JT, Godbole M, Strait KA, Schwartz HL, Oppenheimer JH (1991) Prolonged fasting reduces rat hepatic β l thyroid hormone receptor protein without changing the level of its messenger ribonucleic acid. Endocrinology 129: 2881–2885
Laudet V, Hanni C, Coll J, Catzeflis F, Stehelin D (1992) Evolution of the nuclear receptor gene superfamily. EMBO J 11: 1003–1013
Lazar MA (1993) Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev 14: 184–193
Lee JW, Choi H-S, Gyuris J, Brent R, Moore DD (1995) Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol Endocrinol 9: 243–254
Leeson PD, Emmett JC, Shah VP, Showell GA, Novelli R, Prain HD, Benson MG, Ellis D, Pearce NJ, Underwood AH (1989) Selective thyromimetics. Cardiac-sparing thyroid hormone analogues containing 3’-arylmethyl substituents. J Med Chem 32: 320–336
Lennon AM, Osty J, Nunez J (1980) Cytosolic thyroxine-binding protein and brain development. Mol Cell Endocrinol 18: 201–214
Lennon AM (1992) Purification and characterization of rat brain cytosolic 3,5,3’-triiodo-L-thyronine-binding protein. Eur J Biochem 210: 79–85
Lim C-F, Bernard BF, de Jong M, Docter R, Krenning EP, Hennemann G (1993a) A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. J Clin Endocrinol Metab 76: 318–324
Lim C-F, Docter R, Visser TJ, Krenning EP, Bernard B, van Toor H, de Jong M, Hennemann G (1993b) Inhibition of thyroxine transport into cultured rat hepatocytes by serum of non-uremic critically-ill patients, bilirubin and non-esterified fatty acids. J Clin Endocrinol Metab 76: 1165–1172
Mason JW (1987) Amiodarone. N Engl J Med 316: 455–466
Mazzachi BC, Kennedy JA, Wellby ML, Edwards AM (1992) Effect of fatty acids on rat liver nuclear T3-receptor binding. Metabolism 41: 788–792
Mitchell AM, Manley SW, Mortimer RH (1992a) Uptake of L-tri-iodothyronine by human cultured trophoblast cells. J Endocrinol 133: 483–486
Mitchell AM, Manley SW, Mortimer RH (1992b) Membrane transport of thyroid hormone in the human choriocarcinoma cell line, JAR. Mol Cell Endocrinol 87: 139–145
Mitsuhashi T, Uchimura H, Takaku F (1987) n-Butyrate increases the level of thyroid hormone nuclear receptor in non-pituitary cultured cells. J Biol Chem 262: 3993–3999
Miyoshi Y, Nakamura H, Tagami T, Sasaki S, Nakao K (1994) 3,5,3’-Triiodothyronine stimulates retinoic acid-induced differentiation in HL-60 cells. Mol Cell Endocrinol 103: 119–123
Movius EG, Phyillaier MM, Robbins J (1989) Phloretin inhibits cellular uptake and nuclear receptor binding of triiodothyronine in human Hep G2 hepatocarcinoma cells. Endocrinology 124: 1988–1997
Murray MB, Zilz ND, McCreary NL, MacDonald MJ, Towle HC (1988) Isolation and characterisation of rat cDNA clones for two distinct thyroid hormone receptors. J Biol Chem 263: 12770–12777
Nishii Y, Hashizume K, Ichikawa K, Miyamoto T, Suzuki S, Takeda T, Yamauchi K, Kobayashi M, Yamada T (1989) Changes in cytosolic 3,5,3’-triiodo-L-thyronine (T3) binding activity during administration of L-thyroxine to thyroidectomised rats: cytosolic T3-binding protein and its activator act as intracellular regulators for nuclear T3 binding. J Endocrinol 123: 99–104
Nordeen SK, Bona BJ, Moyer ML (1993) Latent agonist activity of the steroid antagonist, RU486, is unmasked in cells treated with activators of protein kinase A. Mol Endocrinol 7: 731–742
Norman MF, Lavin TN (1989) Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells. J Clin Invest 83: 306–313
Obata T, Kitagawa S, Gong Q-H, Pastan I, Cheng S-Y (1988) Thyroid hormone down-regulates p55, a thyroid hormone-binding protein that is homologous to protein disulfide isomerase and the β-subunit of prolyl-4-hydroxylase. J Biol Chem 263: 782–785
Ortiz-Caro J, Montiel F, Pascual A, Aranda A (1986) Modulation of thyroid hormone nuclear receptors by short-chain fatty acids in glial C6 cells. J Biol Chem 261: 13997–14004
Osty J, Jego L, Francon J, Blondeau J-P (1988a) Characterization of triiodothyronine transport and accumulation in rat erythrocytes. Endocrinology 123: 2303–2311
Osty J, Rappaport L, Samuel JL, Lennon AM (1988b) Characterization of a cytosolic triiodothyronine binding protein in atrium and ventricle of rat heart with different sensitivity toward thyroid hormone levels. Endocrinology 122: 1027–1033
Paradis P, Lambert C, Rouleau J (1991) Amiodarone antagonises the effects of T3 at the receptor level: an additional mechanism for its in vivo hypothyroid-like effects. Can J Physiol Pharmacol 69: 865–870
Parkison C, Ashizawa K, McPhie P, Lin K-H, Cheng S-Y (1991) The monomer of pyruvate kinase, subtype M, is both a kinase and a cytosolic thyroid hormone binding protein. Biochem Biophys Res Comm 179: 668–674
Prasad PD, Leibach FH, Mahesh VB, Ganapathy V (1994) Relationship between thyroid hormone transport and neutral amino acid transport in JAR human choriocarcinoma cells. Endocrinology 134: 574–581
Sadhu DP, Brody S (1947) Excess vitamin A ingestion, thyroid size and energy metabolism. Am J Physiol 149: 400–403
Sakata S, Komaki T, Nakamura S, Ohshima M, Sagisaka K, Yoshioka N, Atassi MZ, Miura K (1990) Binding of thyroid hormones to human hemoglobin and localization of the binding site. J Protein Chem 9: 743–750
Satyanarayana M, Sarvesh A, Khadeer MA, Ved HS, Robert Soprano D, Rajeswari MR, Pieringer RA (1994) Regulation of neuronal thyroid hormone receptor α, mRNA by hydrocortisone, thyroid hormone and retinoic acid. Dev Neurosci 16: 255–259
Schröder-van der Elst JP, van der Heide D (1990) Thyroxine, 3,5,3’-triiodothyronine, and 3,3’,5-triiodothyronine concentrations in several tissues of the rat: effects of amiodarone and desethylamiodarone on thyroid hormone metabolism. Endocrinology 127: 1656–1664
Schwartz HL, Strait KA, Ling NC, Oppenheimer JH (1992) Quantitation of rat tissue thyroid hormone binding receptor isoforms by immunoprecipitation of nuclear triiodothyronine binding capacity. J Biol Chem 267: 11794–11799
Seelig S, Law C, Towle HC, Oppenheimer JH (1981) Thyroid hormone attenuates and augments hepatic gene expression at a pretranslational level. Proc Natl Acad Sci USA 78: 4733–4737
Shull JD, Pennington KL, Gurr JA, Ross AC (1995) Cell-type specific interactions between retinoic acid and thyroid hormone in the regulation of expression of the gene encoding ornithine aminotransferase. Endocrinology 136: 2120–2126
Sugawara A, Yen PM, Chin WW (1994a) 9-cis Retinoic acid regulation of rat growth hormone gene expression: potential roles of multiple nuclear hormone receptors. Endocrinology 135: 1956–1962
Sugawara A, Yen PM, Apriletti JW, Ribeiro RCJ, Sacks DB, Baxter JD, Chin WW (1994b) Phosphorylation selectively increases triiodothyronine receptor homodimer binding to DNA. J Biol Chem 269: 433–437
Suzuki S, Hashizume K, Ichikawa K, Takeda T (1991) Ontogenesis of the high affinity NADPH-dependent cytosolic 3,5,3’-triiodo-L-thyronine-binding protein in rat. Endocrinology 129: 2571–2574
Tagami T, Nakamura H, Sasaki S, Miyoshi Y, Imura H (1993) Estimation of the protein content of thyroid hormone receptor α and β 1 in rat tissues by western blotting. Endocrinology 132: 275–279
Topliss DJ, Kolliniatis E, Barlow JW, Lim C-F, Stockigt JR (1989) Uptake of 3,5,3’-triiodothyronine by cultured rat hepatoma cells is inhibitable by nonbile acid cholephils, diphenylhydantoin, and nonsteroidal antiinflammatory drugs. Endocrinology 124: 980–986
Topliss DJ, Scholz GH, Kolliniatis E, Barlow JW, Stockigt JR (1993) Influence of calmodulin antagonists and calcium channel blockers on triiodothyronine uptake by rat hepatoma and myoblast cell lines. Metabolism 42: 376–380
Underwood AH, Emmett JC, Ellis D, Flynn SB, Leeson PD, Benson GM, Novelli R, Pearce NJ, Shah VP (1986) A thyromimetic that decreases plasma cholesterol levels without increasing cardiac activity. Nature 324: 425–429
Wartofsky L (1993) Has the use of antithyroid drugs for Graves’ disease become obsolete? Thyroid 3: 335–344
Weisiger RA, Luxon BA, Cavalieri RR (1992) Hepatic uptake of 3,5,3’-triiodothyronine: electrochemical driving forces. Am J Physiol 262: G1104–G1112
Williams GR, Franklyn JA, Neuberger J, Sheppard MC (1989) Thyroid hormone receptor expression in the “sick” euthyroid syndrome. Lancet 2: 1477–1481
Williams GR, Franklyn JA, Sheppard MC (1991) Thyroid hormone and glucocorticoid regulation of receptor and target gene mRNAs in pituitary GH3 cells. Mol Cell Endocrinol 80: 127–138
Willams GR, Brent GA (1992) Specificity of nuclear hormone receptor action: who conducts the orchestra? J Endocrinol 135: 191–194
Wolf M, Hansen N, Greten H (1994) Interleukin 1β, tumor necrosis factor-a and interleukin 6 decrease nuclear thyroid hormone receptor capacity in a liver cell line. Eur J Endocrinol 131: 307–312
Yen PM, Chin WW (1994) New advances in understanding the molecular mechanisms of thyroid hormone action. Trends Endocrinol Metab 5: 65–72
Yin Y, Vassy R, Nicolas P, Perret GY, Laurent S (1994) Antagonism between T3 and amiodarone on the contractility and the density of beta-adrenoceptors of chicken cardiac myocytes. Eur J Pharmacol 261: 97–104
Zhang X-K, Pfahl M (1993) Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors. Trends Endocrinol Metab 4: 156–162
Zhou Y, Samson M, Francon J, Blondeau J-P (1992) Thyroid hormone concentrative uptake in rat erythrocytes. Biochem J 281: 81–86
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Barlow, J.W., Crowe, T.C., Topliss, D.J. (1997). Thyroid Hormone Antagonism. In: Weetman, A.P., Grossman, A. (eds) Pharmacotherapeutics of the Thyroid Gland. Handbook of Experimental Pharmacology, vol 128. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60709-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-60709-7_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64519-8
Online ISBN: 978-3-642-60709-7
eBook Packages: Springer Book Archive